agilon health (NYSE:AGL) Releases Quarterly Earnings Results, Misses Estimates By $0.07 EPS

agilon health (NYSE:AGL) announced its quarterly earnings results on Tuesday. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.07), Zacks reports. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%.

agilon health Price Performance

Shares of agilon health stock traded up $0.07 on Tuesday, reaching $3.71. The stock had a trading volume of 6,676,662 shares, compared to its average volume of 5,254,070. The business’s 50 day moving average is $2.85 and its two-hundred day moving average is $3.05. The company has a market cap of $1.53 billion, a P/E ratio of -3.94 and a beta of 0.66. agilon health has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

Insider Buying and Selling

In other agilon health news, Director Karen Mcloughlin bought 25,000 shares of agilon health stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares in the company, valued at $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John William Wulf purchased 45,000 shares of the stock in a transaction on Thursday, December 5th. The stock was acquired at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 77,500 shares of company stock valued at $169,600. Company insiders own 3.20% of the company’s stock.

Analyst Upgrades and Downgrades

AGL has been the subject of several analyst reports. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and increased their target price for the company from $1.75 to $2.25 in a report on Friday, January 10th. Needham & Company LLC started coverage on agilon health in a research report on Friday, January 10th. They issued a “hold” rating on the stock. TD Cowen decreased their target price on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $3.00 price objective on shares of agilon health in a report on Tuesday, November 19th. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, agilon health presently has an average rating of “Hold” and a consensus price target of $4.03.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.